Latest news
Pfizer (NYSE:PFE) climbs 7% after main drugs offset fall in COVID sales - TechStock²TechStock² · Sat, 08 Aug 2026 20:43:30 GMTPfizer beats earnings estimates, targets US$2.5 billion in additional cost cuts - BNN BloombergBNN Bloomberg · Wed, 05 Aug 2026 19:27:13 GMTPfizer Stock Slips Despite Earnings Beat and $2.5 Billion Cuts - TradingViewTradingView · Wed, 05 Aug 2026 15:04:56 GMTPfizer (NYSE:PFE) Shares Gain as Four Major Drugs Compensate for COVID Revenue Hit - TechStock²TechStock² · Wed, 05 Aug 2026 13:59:37 GMTPfizer Q2 2026 Earnings: Non-COVID Growth Raises Revenue Outlook - TradingKeyTradingKey · Wed, 05 Aug 2026 06:34:00 GMTPfizer’s Earnings Beat Came With Another $2.5 Billion Cut - FinimizeFinimize · Wed, 05 Aug 2026 02:47:15 GMTPfizer expands cost-cutting efforts with new $2.5B target - FirstWord PHARMAFirstWord PHARMA · Tue, 04 Aug 2026 23:46:57 GMTPfizer Beats Q2 Estimates with $15 Billion Quarter, Raises Outlook, and Stock Rises as Eliquis and Padcev Lead Growth - BBN TimesBBN Times · Tue, 04 Aug 2026 22:41:06 GMT